| Patents for A61P 13 - Drugs for disorders of the urinary system (56,135) |
|---|
| 09/20/2001 | CA2402898A1 Novel lipoic acid heterocyclic or benzene derivatives, preparation and use thereof as medicines |
| 09/20/2001 | CA2402891A1 Il-8 receptor antagonists |
| 09/20/2001 | CA2400106A1 Antibodies to human cd154 |
| 09/19/2001 | EP1133557A2 Growth factor modulators |
| 09/19/2001 | EP1133491A1 Novel benzofurane derivatives, preparation method, use as medicines and pharmaceutical compositions containing same |
| 09/19/2001 | EP1133487A1 Scavenger compounds |
| 09/19/2001 | EP1133484A2 Heterocyclic derivatives and their use as integrin inhibitors |
| 09/19/2001 | EP1133481A1 Quinoline and quinoxaline compounds as pdgf-r and/or lck tyrosine kinase inhibitors |
| 09/19/2001 | EP1133478A1 Novel acylguanidine derivatives, method for preparing same, application as medicines and pharmaceutical compositions containing them |
| 09/19/2001 | EP1133477A1 Substituted benzimidazoles and their use as parp inhibitors |
| 09/19/2001 | EP1133476A1 Iminoguanidine derivatives, preparation method, use as medicines |
| 09/19/2001 | EP1133467A1 Ion channel modulating agents |
| 09/19/2001 | EP1133288A1 The use of aryl-substituted cyclobutylalkylamines for treating urinary incontinence |
| 09/19/2001 | EP0923529B1 Substitute 4-arylbutyric acid derivatives as matrix metalloprotease inhibitors |
| 09/19/2001 | EP0839144B1 Piperazine derivatives as therapeutic agents |
| 09/19/2001 | EP0612244B1 Endothelin receptor antagonists |
| 09/19/2001 | CN1313775A Methods and materials for the treatment of prostatic cercinoma |
| 09/19/2001 | CN1313284A N-(3-benzofuryl) urea derivative |
| 09/19/2001 | CN1313280A Benzheterocyclic derivatives |
| 09/19/2001 | CN1071329C Aryl glycinamide derivatives, methods of producing these substances and pharmaceutical compositions containing such compounds |
| 09/19/2001 | CN1071328C Arginine angalogues having nitric oxide synthase inhibitor activity |
| 09/19/2001 | CN1071327C Denzothiazine dioxides as endothelin antagonists |
| 09/19/2001 | CN1071318C Ortho-substd. benzoyl guanidines, their preparing process and use as medicine and diagnostic reagent, and medicine contg. same |
| 09/19/2001 | CN1071127C Chinese-western synthetic medicine for treating lithiasis |
| 09/19/2001 | CN1071126C Chinese medicine preparation for curing hyperplasia of prostate and preparing process thereof |
| 09/19/2001 | CN1071118C Pyrazolopyrimidone for treating impotence |
| 09/19/2001 | CN1071114C Injectable mesna solutions |
| 09/18/2001 | US6291522 Cyclopentane heptan(ENE)oic acid, 2-thiocarbamoyloxy and 2-carbamoyloxy compounds as therapeutic agents |
| 09/18/2001 | US6291491 Treatment of type ii diabetes and obesity; antidepressants; decrease gut motility. |
| 09/18/2001 | US6291485 Treatment of post-ptca restenosis |
| 09/18/2001 | US6291458 Morpholinobenzamide salts |
| 09/18/2001 | US6291454 Dithiepino[6,5-b]pyridines, and related compositions and methods |
| 09/18/2001 | US6291451 2-phenyl-1-[4-(2-aminoethoxy)-benzyl]-indoles as estrogenic agents |
| 09/18/2001 | US6291450 Carboxylic acid substituted heterocycles, derivatives thereof and methods of use |
| 09/18/2001 | US6291425 Compounds, methods and pharmaceutical compositions for treating cellular damage, such as neural or cardiovascular tissue damage |
| 09/18/2001 | US6290981 Use of nitric oxide-releasing agents to treat impotency |
| 09/18/2001 | CA2236814C Quinoline and quinazoline compounds useful in therapy |
| 09/18/2001 | CA2145182C Dna encoding human alpha 1 adrenergic receptors and uses thereof |
| 09/15/2001 | WO2001068859A2 Il-17 receptor like molecules and uses thereof |
| 09/15/2001 | CA2403370A1 Il-17 receptor like molecules and uses thereof |
| 09/13/2001 | WO2001066746A2 G-protein coupled receptor related polypeptides |
| 09/13/2001 | WO2001066716A1 Polypeptide having phosphodiesterase activity |
| 09/13/2001 | WO2001066572A2 Polynucleotides isolated from e. coli of nature b2/d+ a-, and uses thereof |
| 09/13/2001 | WO2001066550A2 Compounds for pdt |
| 09/13/2001 | WO2001066548A1 New aza-indolyl derivatives |
| 09/13/2001 | WO2001066544A2 Tricyclic dihydropyrazolone and tricyclic dihydroisoxazolone potassium channel openers |
| 09/13/2001 | WO2001066525A1 New ccr5 modulators: benzimidazoles or benzotriazoles |
| 09/13/2001 | WO2001066140A1 Use of tgf-beta antagonists to treat or to prevent loss of renal function |
| 09/13/2001 | WO2001066110A2 METHOD FOR THE TREATMENT OF RENAL DYSFUNCTION WITH sPLA2 INHIBITORS |
| 09/13/2001 | WO2001066099A2 Use of quinazoline derivatives as angiogenesis inhibitors |
| 09/13/2001 | WO2001030759A3 Sodium-hydrogen exchanger type 1 inhibitor crystals |
| 09/13/2001 | WO2001016288A3 Dna encoding the human serine protease c-e |
| 09/13/2001 | WO2001005805A3 Novel c-19-halogen-substituted, 5-substituted, 5-substituted or 6,10 carbocyclically condensed steroids of the androst-9(11)-ene-series, methods for the production and use thereof |
| 09/13/2001 | WO2000059886A3 Benzimidazole abd imidazolophyridine derivaties, their preparation and their use as selective modulators of bradykinin b2 (=bk-2) receptors |
| 09/13/2001 | US20010021772 Vascular endothelial growth factor |
| 09/13/2001 | US20010021719 2-phenyl-1- [4- (2-aminoethoxy) - benzyl] - indoles as estrogenic agents |
| 09/13/2001 | US20010021708 Acylurea compound containing imidazolidine ring |
| 09/13/2001 | CA2402602A1 Polynucleotides which are of nature b2/d+ a- and which are isolated from e. coli, and biological uses of these polynucleotides and of their polypeptides |
| 09/13/2001 | CA2402433A1 Compounds for pdt |
| 09/13/2001 | CA2402179A1 Tricyclic dihydropyrazolone and tricyclic dihydroisoxazolone potassium channel openers |
| 09/13/2001 | CA2401549A1 G-protein coupled receptor related polypeptides |
| 09/13/2001 | CA2401524A1 New ccr5 modulators: benzimidazoles or benzotriazoles |
| 09/13/2001 | CA2400628A1 Use of tgf-beta antagonists to treat or to prevent loss of renal function |
| 09/13/2001 | CA2399111A1 New aza-indolyl derivatives |
| 09/12/2001 | EP1132389A1 New aza-indolyl derivatives for the treatment of obesity |
| 09/12/2001 | EP1132089A1 Extract from loquat seeds against fibrosis |
| 09/12/2001 | EP1132086A2 Use of prostaglandin (PGE2) receptor 4 (EP4) selective agonists for the treatment of acute and chronic renal failure |
| 09/12/2001 | EP1131445A1 Human phospholipases |
| 09/12/2001 | EP1131443A2 Human hydrolase proteins |
| 09/12/2001 | EP1131428A2 Immunoglobulin superfamily proteins |
| 09/12/2001 | EP1131337A1 Novel betulinic acid derivatives, processes for preparing such derivatives and its use as cancer growth inhibitors |
| 09/12/2001 | EP1131322A2 Dihydropyridine compounds and methods of use |
| 09/12/2001 | EP1131317A1 Method for preparing (2s)-1- (2r,3s)-5- chloro-3-(2- chlorophenyl) -1-(3,4-dimethoxy benzenesulphonyl) -3-hydroxy-2, 3-dihydro-1h- indole-2-carbonyl] pyrrolidine-2- carboxamide |
| 09/12/2001 | EP1131302A1 Substituted 4-amino-2-aryl-cyclopenta d]pyrimidines, their production and use and pharmaceuticalreparations containing same |
| 09/12/2001 | EP1131301A1 2-phenylbenzimidazoles and 2-phenylindoles, and production and use thereof |
| 09/12/2001 | EP1131295A1 Quinoline-4-carboxamide derivatives as nk-3 and nk-2 receptor antagonists |
| 09/12/2001 | EP1131293A1 1-aminoethylquinoline derivatives for treating urinary incontinence |
| 09/12/2001 | EP1044200A4 Preparation of terazosin hydrochloride dihydrate |
| 09/12/2001 | EP0991424B1 Pharmaceutical compositions comprising an aldose reductase inhibitor and an ace inhibitor |
| 09/12/2001 | EP0831864B1 Processed ginseng having enhanced pharmacological effect |
| 09/12/2001 | EP0822826B1 Nitrosylated neuropeptides |
| 09/12/2001 | EP0817775B1 Quinazoline derivatives |
| 09/12/2001 | CN1312802A Cycloalkyl-substituted aryl-piperazines, piperidines and tetrahydropyridines as serotonergic agents |
| 09/12/2001 | CN1312800A Therapeutic biaryl derivatives |
| 09/12/2001 | CN1312719A Pharmaceutical Composition |
| 09/12/2001 | CN1312715A Antihypersensitive combination of valsartan and calcium channel blocker |
| 09/12/2001 | CN1312102A Life essence-filling, marrow-benefitting and kidney invigorating Chinese medicine preparation |
| 09/12/2001 | CN1070701C Pyrimidine ortriazine carboxylic acid derivatives to be used as medicaments |
| 09/11/2001 | US6288278 Benzene derived amino alcohols as drugs |
| 09/11/2001 | US6288120 Prevention of loss and restoration of bone mass by certain prostaglandin agonists |
| 09/11/2001 | US6288116 Administering mixture containing protein, fats, vitamins, carbohydrates and minerals and arginine and an arginine-neutralizing acid selected from lactic, malic and adipic acids or mixtures |
| 09/11/2001 | US6288055 Analgesic agents |
| 09/11/2001 | US6287786 Nucleic acid molecules encoding a new mammalian protein and to the use of these molecules in the characterization, diagnosis, and treatment of conditions such as disorders associated with cell proliferation, lipid metabolism and transport. |
| 09/11/2001 | US6287576 Biostimulating agent |
| 09/11/2001 | CA2230936C 5-azabicyclo(3.1.0)hexylalkyl-2-piperidones and -glutarimides as neurokinin receptor antagonists |
| 09/07/2001 | WO2001064879A2 G-proteins coupled receptor related polypeptides |
| 09/07/2001 | WO2001064862A1 Human monoclonal antibodies against oxidized ldl receptor and medicinal use thereof |
| 09/07/2001 | WO2001064837A2 β NETRIN AND USES THEREOF |
| 09/07/2001 | WO2001064749A2 Method for preparing anti-mif antibodies |
| 09/07/2001 | WO2001064692A1 Cardioprotective phosphonates and malonates |